secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atea Pharmaceuticals, Inc. (AVIR)
CIK:        0001593899
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001193125-24-165886
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Atea Pharmaceuticals re-elects two Class I directors; Berger receives 48% withhold votes
--------------------------------------------------------------------------------

- Franklin Berger elected with 30.5M for, 28.3M withheld (48% withhold); Sommadossi elected with 40.8M for, 18.1M withheld.
- KPMG LLP ratified as auditor for FY2024: 62.3M for, 6.5M against, 5.6M abstain.
- Say-on-pay proposal approved on advisory basis: 42.9M for, 15.5M against, 0.4M abstain.
- 88.3% of outstanding shares voted (74.4M of 84.3M shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593899/000119312524165886/0001193125-24-165886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593899/000119312524165886/d891172d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-165886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer